Cargando…

Nanoparticle-Based Combination Therapy for Melanoma

Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongbo, Hou, Kai, Yu, Jing, Wang, Le, Chen, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273962/
https://www.ncbi.nlm.nih.gov/pubmed/35837089
http://dx.doi.org/10.3389/fonc.2022.928797
_version_ 1784745210351190016
author Chen, Hongbo
Hou, Kai
Yu, Jing
Wang, Le
Chen, Xue
author_facet Chen, Hongbo
Hou, Kai
Yu, Jing
Wang, Le
Chen, Xue
author_sort Chen, Hongbo
collection PubMed
description Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious complications; moreover, resistance is common. Nanoparticles (NPs) combined with conventional methods are new and promising options to treat melanoma, and many combinations have been achieving good success. Due to their physical and biological features, NPs can help target intended melanoma cells more efficiently with less damage. This creates new hope for a better treatment strategy for melanoma with minimum damage and maximum efficacy.
format Online
Article
Text
id pubmed-9273962
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92739622022-07-13 Nanoparticle-Based Combination Therapy for Melanoma Chen, Hongbo Hou, Kai Yu, Jing Wang, Le Chen, Xue Front Oncol Oncology Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious complications; moreover, resistance is common. Nanoparticles (NPs) combined with conventional methods are new and promising options to treat melanoma, and many combinations have been achieving good success. Due to their physical and biological features, NPs can help target intended melanoma cells more efficiently with less damage. This creates new hope for a better treatment strategy for melanoma with minimum damage and maximum efficacy. Frontiers Media S.A. 2022-06-28 /pmc/articles/PMC9273962/ /pubmed/35837089 http://dx.doi.org/10.3389/fonc.2022.928797 Text en Copyright © 2022 Chen, Hou, Yu, Wang and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Chen, Hongbo
Hou, Kai
Yu, Jing
Wang, Le
Chen, Xue
Nanoparticle-Based Combination Therapy for Melanoma
title Nanoparticle-Based Combination Therapy for Melanoma
title_full Nanoparticle-Based Combination Therapy for Melanoma
title_fullStr Nanoparticle-Based Combination Therapy for Melanoma
title_full_unstemmed Nanoparticle-Based Combination Therapy for Melanoma
title_short Nanoparticle-Based Combination Therapy for Melanoma
title_sort nanoparticle-based combination therapy for melanoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273962/
https://www.ncbi.nlm.nih.gov/pubmed/35837089
http://dx.doi.org/10.3389/fonc.2022.928797
work_keys_str_mv AT chenhongbo nanoparticlebasedcombinationtherapyformelanoma
AT houkai nanoparticlebasedcombinationtherapyformelanoma
AT yujing nanoparticlebasedcombinationtherapyformelanoma
AT wangle nanoparticlebasedcombinationtherapyformelanoma
AT chenxue nanoparticlebasedcombinationtherapyformelanoma